205 related articles for article (PubMed ID: 31020919)
1. Research and policy priorities for addressing prenatal exposure to opioids in Alaska.
Singleton R; Slaunwhite A; Herrick M; Hirschfeld M; Brunner L; Hallas C; Truit S; Hanson S; Young M; Rider E
Int J Circumpolar Health; 2019 Dec; 78(1):1599275. PubMed ID: 31020919
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.
Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A
J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916
[TBL] [Abstract][Full Text] [Related]
3. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018.
Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB
Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554
[No Abstract] [Full Text] [Related]
4. Implications of Tennessee's Opioid Legislation for Neonatal Abstinence Syndrome.
Shearer JN; Erwin PC; Davis SK; Anderson JG; Lindley LC
Policy Polit Nurs Pract; 2019 Aug; 20(3):153-162. PubMed ID: 31390304
[TBL] [Abstract][Full Text] [Related]
5. State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.
Kroelinger CD; Rice ME; Cox S; Hickner HR; Weber MK; Romero L; Ko JY; Addison D; Mueller T; Shapiro-Mendoza C; Fehrenbach SN; Honein MA; Barfield WD
MMWR Morb Mortal Wkly Rep; 2019 Sep; 68(36):777-783. PubMed ID: 31513558
[TBL] [Abstract][Full Text] [Related]
6. Understanding barriers to timely identification of infants at risk of neonatal opiate withdrawal syndrome.
Howell MP; Smith AM; Lindsay EB; Drury SS
J Matern Fetal Neonatal Med; 2021 Apr; 34(7):1161-1166. PubMed ID: 31195865
[TBL] [Abstract][Full Text] [Related]
7. Racial differences in opioid withdrawal syndrome among neonates with intrauterine opioid exposure.
Pourcyrous M; Elabiad MT; Rana D; Gaston KP; DeBaer L; Dhanireddy R
Pediatr Res; 2021 Aug; 90(2):459-463. PubMed ID: 33214673
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
[TBL] [Abstract][Full Text] [Related]
9. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
[TBL] [Abstract][Full Text] [Related]
10. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
Velez ML; Jordan C; Jansson LM
Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
[TBL] [Abstract][Full Text] [Related]
11. Conceptualizing Neonatal Abstinence Syndrome as a Cascade of Care: A Qualitative Study With Healthcare Providers in Ohio.
Syvertsen JL; Toneff H; Madden DR; Clapp JD
Adv Neonatal Care; 2018 Dec; 18(6):488-499. PubMed ID: 30234507
[TBL] [Abstract][Full Text] [Related]
12. The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention.
Wine O; McNeil D; Kromm SK; Foss K; Caine V; Clarke D; Day N; Johnson DW; Rittenbach K; Wood S; Hicks M
BMC Health Serv Res; 2023 May; 23(1):448. PubMed ID: 37149626
[TBL] [Abstract][Full Text] [Related]
13. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
[No Abstract] [Full Text] [Related]
14. A Practical Approach to Neonatal Opiate Withdrawal Syndrome.
Devlin LA; Davis JM
Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261
[TBL] [Abstract][Full Text] [Related]
15. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.
Velez ML; Jordan CJ; Jansson LM
Neurotoxicol Teratol; 2021; 88():107020. PubMed ID: 34419619
[TBL] [Abstract][Full Text] [Related]
16. Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis.
Weller AE; Crist RC; Reiner BC; Doyle GA; Berrettini WH
Cold Spring Harb Perspect Med; 2021 Mar; 11(3):. PubMed ID: 32229609
[TBL] [Abstract][Full Text] [Related]
17. Could prenatal food insecurity influence neonatal abstinence syndrome severity?
Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM
Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365
[TBL] [Abstract][Full Text] [Related]
18. Neonatal Abstinence Syndrome.
Jansson LM; Patrick SW
Pediatr Clin North Am; 2019 Apr; 66(2):353-367. PubMed ID: 30819342
[TBL] [Abstract][Full Text] [Related]
19. Transitioning Care Approach for Neonatal Opioid Withdrawal Syndrome and Neonatal Abstinence Syndrome.
Perez C
Crit Care Nurs Clin North Am; 2024 Jun; 36(2):223-233. PubMed ID: 38705690
[TBL] [Abstract][Full Text] [Related]
20. Opioids affect the fetal brain: reframing the detoxification debate.
Caritis SN; Panigrahy A
Am J Obstet Gynecol; 2019 Dec; 221(6):602-608. PubMed ID: 31323217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
